Drugs that mimic glucagonlike peptide-1 (GLP-1), such as semaglutidemarketed as Ozempic or Wegovyhave revolutionized the treatment of obesity and type 2 diabetes, but they have major drawbacks
For the vast majority of people, once or twice daily dosing of 250-500 mcg provides excellent results for injury recovery, gut healing, and tissue repair
But once it becomes approved, retatrutide may represent the most powerful therapeutic option ever introduced for severe obesity and metabolic disease.
Frequently utilized during the reconstitution of compounds such as AOD-9604, Tesamorelin, CJC-1295, MOTS-C, Kisspeptin-10, and other peptides known to occasionally exhibit solubility challenges
Key trials include TRIUMPH-1 (obesity without diabetes, primary weight loss endpoint at 72 weeks), TRIUMPH-2 (obesity with type 2 diabetes), and TRIUMPH-CVOT (cardiovascular outcomes in adults with overweight or obesity and established cardiovascular disease, mirroring the SELECT trial design)
Three to five prunes daily or 4-6 ounces of prune juice provides meaningful benefit